InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: Riskreturn168 post# 90662

Friday, 12/27/2013 11:11:28 AM

Friday, December 27, 2013 11:11:28 AM

Post# of 130516
Partnership with Becton Dickinson for LymPro or a partnership with Novartis for MANF will make the additional shares irrelevant.

A few more shares in the float will be beneficial to the up listing to the NASDAQ.

"Patience is a virtue."

Twitter: @AmarantusBio